Cargando…
PB2164: EFFICACY AND SAFETY EVALUATION OF IXAZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IN THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428681/ http://dx.doi.org/10.1097/01.HS9.0000975416.81383.b0 |
| _version_ | 1785090527121637376 |
|---|---|
| author | LI, Wen Zhang, Zhipeng Zhou, Zhigang Liu, Hong Huang, Hongming Lu, Kai Ren, Haijuan Lin, Zenghua |
| author_facet | LI, Wen Zhang, Zhipeng Zhou, Zhigang Liu, Hong Huang, Hongming Lu, Kai Ren, Haijuan Lin, Zenghua |
| author_sort | LI, Wen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428681 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104286812023-08-17 PB2164: EFFICACY AND SAFETY EVALUATION OF IXAZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IN THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA LI, Wen Zhang, Zhipeng Zhou, Zhigang Liu, Hong Huang, Hongming Lu, Kai Ren, Haijuan Lin, Zenghua Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428681/ http://dx.doi.org/10.1097/01.HS9.0000975416.81383.b0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only LI, Wen Zhang, Zhipeng Zhou, Zhigang Liu, Hong Huang, Hongming Lu, Kai Ren, Haijuan Lin, Zenghua PB2164: EFFICACY AND SAFETY EVALUATION OF IXAZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IN THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title | PB2164: EFFICACY AND SAFETY EVALUATION OF IXAZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IN THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full | PB2164: EFFICACY AND SAFETY EVALUATION OF IXAZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IN THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_fullStr | PB2164: EFFICACY AND SAFETY EVALUATION OF IXAZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IN THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full_unstemmed | PB2164: EFFICACY AND SAFETY EVALUATION OF IXAZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IN THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_short | PB2164: EFFICACY AND SAFETY EVALUATION OF IXAZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IN THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_sort | pb2164: efficacy and safety evaluation of ixazomib, pomalidomide, and dexamethasone in the treatment of relapsed/refractory multiple myeloma |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428681/ http://dx.doi.org/10.1097/01.HS9.0000975416.81383.b0 |
| work_keys_str_mv | AT liwen pb2164efficacyandsafetyevaluationofixazomibpomalidomideanddexamethasoneinthetreatmentofrelapsedrefractorymultiplemyeloma AT zhangzhipeng pb2164efficacyandsafetyevaluationofixazomibpomalidomideanddexamethasoneinthetreatmentofrelapsedrefractorymultiplemyeloma AT zhouzhigang pb2164efficacyandsafetyevaluationofixazomibpomalidomideanddexamethasoneinthetreatmentofrelapsedrefractorymultiplemyeloma AT liuhong pb2164efficacyandsafetyevaluationofixazomibpomalidomideanddexamethasoneinthetreatmentofrelapsedrefractorymultiplemyeloma AT huanghongming pb2164efficacyandsafetyevaluationofixazomibpomalidomideanddexamethasoneinthetreatmentofrelapsedrefractorymultiplemyeloma AT lukai pb2164efficacyandsafetyevaluationofixazomibpomalidomideanddexamethasoneinthetreatmentofrelapsedrefractorymultiplemyeloma AT renhaijuan pb2164efficacyandsafetyevaluationofixazomibpomalidomideanddexamethasoneinthetreatmentofrelapsedrefractorymultiplemyeloma AT linzenghua pb2164efficacyandsafetyevaluationofixazomibpomalidomideanddexamethasoneinthetreatmentofrelapsedrefractorymultiplemyeloma |